DE & I Localization: Enhancing diversity in clinical trials

80% of clinical trials are delayed due to patient recruitment issues

In 2020, the FDA issued guidance on strengthening representation in clinical trials, stressing the importance of patient diversity in improving health outcomes. But many BioPharma companies don’t have the time, tools, and resources to make trials more accessible.

MAKING DIVERSITY A PRIORITY

To improve outcomes, organizations must ensure everyone has access to clinical trial opportunities. Centific understands:

Cultural and identity nuances that influence patient engagement
Literacy levels needed to comprehend health-related topics
Language barriers that can prevent access to relevant information
Different communication preferences of participants within a population

DE & I SERVICES FOR BIOPHARMA ORGANIZATIONS

Dragonfly: See experience through patients’ eyes
OneForma: Create culturally sensitive content
JourneyMate: Remove barriers to patient participation

Download PDF